On July 26, 2021 OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec") reported that Interim CEO and Chief Operating Officer, Brian Leuthner, and Senior Vice President, Chief Clinical Development Officer, Sandra Aung, Ph.D., will participate in a fireside chat at the BTIG Virtual Biotechnology Conference being held Monday, August, 9th – Tuesday, August 10th, 2021 (Press release, OncoSec Medical, JUL 26, 2021, View Source [SID1234585190]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BTIG Virtual Biotechnology Conference
Date: Monday, August 9th
Time: 2:00pm ET

For those not attending, a replay of the presentation will be available until the end of the conference on the BTIG conference website. Must be a BTIG client to attend and access the replay.